nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotaxime—SLC15A2—multiple sclerosis	0.738	1	CbGaD
Cefotaxime—SLC22A11—Methotrexate—multiple sclerosis	0.0555	0.34	CbGbCtD
Cefotaxime—SLC22A7—Methotrexate—multiple sclerosis	0.0529	0.324	CbGbCtD
Cefotaxime—SLC22A8—Methotrexate—multiple sclerosis	0.0323	0.198	CbGbCtD
Cefotaxime—SLC22A6—Methotrexate—multiple sclerosis	0.0225	0.138	CbGbCtD
Cefotaxime—SLC15A1—Proton/oligonucleotide cotransporters—SLC15A2—multiple sclerosis	0.00152	0.395	CbGpPWpGaD
Cefotaxime—Ceftibuten—SLC15A2—multiple sclerosis	0.00087	0.116	CrCbGaD
Cefotaxime—Cefazolin—PON1—multiple sclerosis	0.000815	0.108	CrCbGaD
Cefotaxime—Cefepime—SLC15A2—multiple sclerosis	0.000716	0.0954	CrCbGaD
Cefotaxime—Cefuroxime—SLC15A2—multiple sclerosis	0.000649	0.0863	CrCbGaD
Cefotaxime—Encephalopathy—Methotrexate—multiple sclerosis	0.000631	0.00723	CcSEcCtD
Cefotaxime—Haemoglobin—Cladribine—multiple sclerosis	0.000625	0.00716	CcSEcCtD
Cefotaxime—Haemorrhage—Cladribine—multiple sclerosis	0.000621	0.00712	CcSEcCtD
Cefotaxime—Erythema multiforme—Cladribine—multiple sclerosis	0.000588	0.00673	CcSEcCtD
Cefotaxime—Candida infection—Triamcinolone—multiple sclerosis	0.000586	0.00671	CcSEcCtD
Cefotaxime—Cefixime—SLC15A2—multiple sclerosis	0.000561	0.0746	CrCbGaD
Cefotaxime—Stevens-Johnson syndrome—Azathioprine—multiple sclerosis	0.000558	0.0064	CcSEcCtD
Cefotaxime—Arrhythmia—Cladribine—multiple sclerosis	0.000555	0.00636	CcSEcCtD
Cefotaxime—Pruritus—Fingolimod—multiple sclerosis	0.000551	0.00631	CcSEcCtD
Cefotaxime—Diarrhoea—Fingolimod—multiple sclerosis	0.000533	0.00611	CcSEcCtD
Cefotaxime—Ceftazidime—SLC15A2—multiple sclerosis	0.000527	0.0702	CrCbGaD
Cefotaxime—Agranulocytosis—Azathioprine—multiple sclerosis	0.000525	0.00602	CcSEcCtD
Cefotaxime—Cefdinir—SLC15A2—multiple sclerosis	0.000517	0.0689	CrCbGaD
Cefotaxime—Cefaclor—SLC15A2—multiple sclerosis	0.000513	0.0682	CrCbGaD
Cefotaxime—Haemoglobin—Azathioprine—multiple sclerosis	0.000508	0.00582	CcSEcCtD
Cefotaxime—Dermatitis bullous—Prednisolone—multiple sclerosis	0.000507	0.00581	CcSEcCtD
Cefotaxime—Haemorrhage—Azathioprine—multiple sclerosis	0.000505	0.00579	CcSEcCtD
Cefotaxime—Ill-defined disorder—Cladribine—multiple sclerosis	0.000502	0.00575	CcSEcCtD
Cefotaxime—Cefradine—SLC15A2—multiple sclerosis	0.000492	0.0654	CrCbGaD
Cefotaxime—Headache—Fingolimod—multiple sclerosis	0.000488	0.00559	CcSEcCtD
Cefotaxime—Malaise—Cladribine—multiple sclerosis	0.000488	0.00559	CcSEcCtD
Cefotaxime—Erythema multiforme—Azathioprine—multiple sclerosis	0.000478	0.00548	CcSEcCtD
Cefotaxime—Neutropenia—Mitoxantrone—multiple sclerosis	0.000477	0.00547	CcSEcCtD
Cefotaxime—Dermatitis bullous—Triamcinolone—multiple sclerosis	0.000466	0.00534	CcSEcCtD
Cefotaxime—Cefadroxil—SLC15A2—multiple sclerosis	0.000465	0.0619	CrCbGaD
Cefotaxime—Discomfort—Cladribine—multiple sclerosis	0.000455	0.00521	CcSEcCtD
Cefotaxime—Arrhythmia—Azathioprine—multiple sclerosis	0.000451	0.00517	CcSEcCtD
Cefotaxime—Renal failure—Mitoxantrone—multiple sclerosis	0.000447	0.00513	CcSEcCtD
Cefotaxime—Jaundice—Mitoxantrone—multiple sclerosis	0.000444	0.00508	CcSEcCtD
Cefotaxime—Thrombocytopenia—Cladribine—multiple sclerosis	0.000432	0.00495	CcSEcCtD
Cefotaxime—Agranulocytosis—Mitoxantrone—multiple sclerosis	0.000425	0.00487	CcSEcCtD
Cefotaxime—Dermatitis bullous—Betamethasone—multiple sclerosis	0.000423	0.00485	CcSEcCtD
Cefotaxime—Dermatitis bullous—Dexamethasone—multiple sclerosis	0.000423	0.00485	CcSEcCtD
Cefotaxime—Haemoglobin—Mitoxantrone—multiple sclerosis	0.000411	0.0047	CcSEcCtD
Cefotaxime—Haemorrhage—Mitoxantrone—multiple sclerosis	0.000408	0.00468	CcSEcCtD
Cefotaxime—Hepatitis—Mitoxantrone—multiple sclerosis	0.000408	0.00468	CcSEcCtD
Cefotaxime—Ill-defined disorder—Azathioprine—multiple sclerosis	0.000408	0.00468	CcSEcCtD
Cefotaxime—Vaginal inflammation—Methotrexate—multiple sclerosis	0.000405	0.00464	CcSEcCtD
Cefotaxime—Ceftriaxone—SLC15A2—multiple sclerosis	0.000399	0.0532	CrCbGaD
Cefotaxime—Malaise—Azathioprine—multiple sclerosis	0.000397	0.00455	CcSEcCtD
Cefotaxime—Leukopenia—Azathioprine—multiple sclerosis	0.000394	0.00451	CcSEcCtD
Cefotaxime—Vaginal infection—Methotrexate—multiple sclerosis	0.000383	0.00438	CcSEcCtD
Cefotaxime—Aplastic anaemia—Methotrexate—multiple sclerosis	0.00038	0.00436	CcSEcCtD
Cefotaxime—Bronchospasm—Methylprednisolone—multiple sclerosis	0.000378	0.00433	CcSEcCtD
Cefotaxime—Pain—Cladribine—multiple sclerosis	0.000378	0.00433	CcSEcCtD
Cefotaxime—Discomfort—Azathioprine—multiple sclerosis	0.00037	0.00424	CcSEcCtD
Cefotaxime—Arrhythmia—Mitoxantrone—multiple sclerosis	0.000365	0.00418	CcSEcCtD
Cefotaxime—Feeling abnormal—Cladribine—multiple sclerosis	0.000364	0.00417	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Cladribine—multiple sclerosis	0.000361	0.00414	CcSEcCtD
Cefotaxime—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000351	0.00403	CcSEcCtD
Cefotaxime—Urticaria—Cladribine—multiple sclerosis	0.000351	0.00402	CcSEcCtD
Cefotaxime—Cefalotin—SLC15A2—multiple sclerosis	0.00035	0.0466	CrCbGaD
Cefotaxime—Abdominal pain—Cladribine—multiple sclerosis	0.000349	0.004	CcSEcCtD
Cefotaxime—Body temperature increased—Cladribine—multiple sclerosis	0.000349	0.004	CcSEcCtD
Cefotaxime—Haemoglobin—Prednisolone—multiple sclerosis	0.000337	0.00386	CcSEcCtD
Cefotaxime—Haemorrhage—Prednisolone—multiple sclerosis	0.000335	0.00384	CcSEcCtD
Cefotaxime—Ill-defined disorder—Mitoxantrone—multiple sclerosis	0.00033	0.00378	CcSEcCtD
Cefotaxime—Hypersensitivity—Cladribine—multiple sclerosis	0.000325	0.00373	CcSEcCtD
Cefotaxime—Malaise—Mitoxantrone—multiple sclerosis	0.000321	0.00367	CcSEcCtD
Cefotaxime—Leukopenia—Mitoxantrone—multiple sclerosis	0.000318	0.00365	CcSEcCtD
Cefotaxime—Cephalexin—SLC15A2—multiple sclerosis	0.000318	0.0423	CrCbGaD
Cefotaxime—Pruritus—Cladribine—multiple sclerosis	0.000312	0.00358	CcSEcCtD
Cefotaxime—Haemoglobin—Triamcinolone—multiple sclerosis	0.00031	0.00355	CcSEcCtD
Cefotaxime—Haemoglobin—Methylprednisolone—multiple sclerosis	0.000309	0.00354	CcSEcCtD
Cefotaxime—Haemorrhage—Triamcinolone—multiple sclerosis	0.000308	0.00353	CcSEcCtD
Cefotaxime—Convulsion—Mitoxantrone—multiple sclerosis	0.000308	0.00353	CcSEcCtD
Cefotaxime—Haemorrhage—Methylprednisolone—multiple sclerosis	0.000307	0.00352	CcSEcCtD
Cefotaxime—Diarrhoea—Cladribine—multiple sclerosis	0.000302	0.00346	CcSEcCtD
Cefotaxime—Arrhythmia—Prednisolone—multiple sclerosis	0.000299	0.00343	CcSEcCtD
Cefotaxime—Discomfort—Mitoxantrone—multiple sclerosis	0.000299	0.00343	CcSEcCtD
Cefotaxime—Feeling abnormal—Azathioprine—multiple sclerosis	0.000296	0.00339	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000294	0.00336	CcSEcCtD
Cefotaxime—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.00029	0.00333	CcSEcCtD
Cefotaxime—Shock—Mitoxantrone—multiple sclerosis	0.000286	0.00327	CcSEcCtD
Cefotaxime—Neutropenia—Prednisone—multiple sclerosis	0.000284	0.00326	CcSEcCtD
Cefotaxime—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000284	0.00326	CcSEcCtD
Cefotaxime—Body temperature increased—Azathioprine—multiple sclerosis	0.000284	0.00325	CcSEcCtD
Cefotaxime—Abdominal pain—Azathioprine—multiple sclerosis	0.000284	0.00325	CcSEcCtD
Cefotaxime—Haemoglobin—Betamethasone—multiple sclerosis	0.000281	0.00322	CcSEcCtD
Cefotaxime—Haemoglobin—Dexamethasone—multiple sclerosis	0.000281	0.00322	CcSEcCtD
Cefotaxime—Vomiting—Cladribine—multiple sclerosis	0.000281	0.00322	CcSEcCtD
Cefotaxime—Haemorrhage—Betamethasone—multiple sclerosis	0.00028	0.0032	CcSEcCtD
Cefotaxime—Haemorrhage—Dexamethasone—multiple sclerosis	0.00028	0.0032	CcSEcCtD
Cefotaxime—Rash—Cladribine—multiple sclerosis	0.000278	0.00319	CcSEcCtD
Cefotaxime—Dermatitis—Cladribine—multiple sclerosis	0.000278	0.00319	CcSEcCtD
Cefotaxime—Headache—Cladribine—multiple sclerosis	0.000277	0.00317	CcSEcCtD
Cefotaxime—Arrhythmia—Triamcinolone—multiple sclerosis	0.000275	0.00315	CcSEcCtD
Cefotaxime—Arrhythmia—Methylprednisolone—multiple sclerosis	0.000275	0.00315	CcSEcCtD
Cefotaxime—Ill-defined disorder—Prednisolone—multiple sclerosis	0.000271	0.0031	CcSEcCtD
Cefotaxime—Angioedema—Prednisolone—multiple sclerosis	0.000267	0.00305	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	0.000265	0.00304	CcSEcCtD
Cefotaxime—Hypersensitivity—Azathioprine—multiple sclerosis	0.000264	0.00303	CcSEcCtD
Cefotaxime—Malaise—Prednisolone—multiple sclerosis	0.000263	0.00301	CcSEcCtD
Cefotaxime—Nausea—Cladribine—multiple sclerosis	0.000262	0.00301	CcSEcCtD
Cefotaxime—Convulsion—Prednisolone—multiple sclerosis	0.000253	0.0029	CcSEcCtD
Cefotaxime—Eosinophilia—Methotrexate—multiple sclerosis	0.000252	0.00288	CcSEcCtD
Cefotaxime—Arrhythmia—Dexamethasone—multiple sclerosis	0.00025	0.00286	CcSEcCtD
Cefotaxime—Arrhythmia—Betamethasone—multiple sclerosis	0.00025	0.00286	CcSEcCtD
Cefotaxime—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000249	0.00285	CcSEcCtD
Cefotaxime—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000248	0.00285	CcSEcCtD
Cefotaxime—Pain—Mitoxantrone—multiple sclerosis	0.000248	0.00284	CcSEcCtD
Cefotaxime—Diarrhoea—Azathioprine—multiple sclerosis	0.000246	0.00281	CcSEcCtD
Cefotaxime—Discomfort—Prednisolone—multiple sclerosis	0.000245	0.00281	CcSEcCtD
Cefotaxime—Angioedema—Triamcinolone—multiple sclerosis	0.000245	0.00281	CcSEcCtD
Cefotaxime—Haemoglobin—Prednisone—multiple sclerosis	0.000245	0.0028	CcSEcCtD
Cefotaxime—Angioedema—Methylprednisolone—multiple sclerosis	0.000245	0.0028	CcSEcCtD
Cefotaxime—Haemorrhage—Prednisone—multiple sclerosis	0.000244	0.00279	CcSEcCtD
Cefotaxime—Malaise—Triamcinolone—multiple sclerosis	0.000242	0.00277	CcSEcCtD
Cefotaxime—Malaise—Methylprednisolone—multiple sclerosis	0.000241	0.00277	CcSEcCtD
Cefotaxime—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000239	0.00274	CcSEcCtD
Cefotaxime—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000238	0.00273	CcSEcCtD
Cefotaxime—Neutropenia—Methotrexate—multiple sclerosis	0.000238	0.00272	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000237	0.00272	CcSEcCtD
Cefotaxime—Shock—Prednisolone—multiple sclerosis	0.000234	0.00268	CcSEcCtD
Cefotaxime—Convulsion—Triamcinolone—multiple sclerosis	0.000232	0.00266	CcSEcCtD
Cefotaxime—Convulsion—Methylprednisolone—multiple sclerosis	0.000232	0.00266	CcSEcCtD
Cefotaxime—Urticaria—Mitoxantrone—multiple sclerosis	0.000231	0.00264	CcSEcCtD
Cefotaxime—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000229	0.00263	CcSEcCtD
Cefotaxime—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000229	0.00263	CcSEcCtD
Cefotaxime—Vomiting—Azathioprine—multiple sclerosis	0.000228	0.00262	CcSEcCtD
Cefotaxime—Rash—Azathioprine—multiple sclerosis	0.000226	0.00259	CcSEcCtD
Cefotaxime—Dermatitis—Azathioprine—multiple sclerosis	0.000226	0.00259	CcSEcCtD
Cefotaxime—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000226	0.00259	CcSEcCtD
Cefotaxime—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000226	0.00259	CcSEcCtD
Cefotaxime—Discomfort—Triamcinolone—multiple sclerosis	0.000226	0.00259	CcSEcCtD
Cefotaxime—Discomfort—Methylprednisolone—multiple sclerosis	0.000225	0.00258	CcSEcCtD
Cefotaxime—Headache—Azathioprine—multiple sclerosis	0.000225	0.00258	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000225	0.00258	CcSEcCtD
Cefotaxime—Renal failure—Methotrexate—multiple sclerosis	0.000223	0.00255	CcSEcCtD
Cefotaxime—Angioedema—Dexamethasone—multiple sclerosis	0.000222	0.00255	CcSEcCtD
Cefotaxime—Angioedema—Betamethasone—multiple sclerosis	0.000222	0.00255	CcSEcCtD
Cefotaxime—Malaise—Dexamethasone—multiple sclerosis	0.00022	0.00252	CcSEcCtD
Cefotaxime—Malaise—Betamethasone—multiple sclerosis	0.00022	0.00252	CcSEcCtD
Cefotaxime—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000219	0.00251	CcSEcCtD
Cefotaxime—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000218	0.0025	CcSEcCtD
Cefotaxime—Arrhythmia—Prednisone—multiple sclerosis	0.000218	0.00249	CcSEcCtD
Cefotaxime—Shock—Triamcinolone—multiple sclerosis	0.000215	0.00247	CcSEcCtD
Cefotaxime—Shock—Methylprednisolone—multiple sclerosis	0.000215	0.00246	CcSEcCtD
Cefotaxime—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000214	0.00245	CcSEcCtD
Cefotaxime—Nausea—Azathioprine—multiple sclerosis	0.000213	0.00244	CcSEcCtD
Cefotaxime—Agranulocytosis—Methotrexate—multiple sclerosis	0.000212	0.00242	CcSEcCtD
Cefotaxime—Convulsion—Betamethasone—multiple sclerosis	0.000211	0.00242	CcSEcCtD
Cefotaxime—Convulsion—Dexamethasone—multiple sclerosis	0.000211	0.00242	CcSEcCtD
Cefotaxime—SLC22A7—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.00021	0.0544	CbGpPWpGaD
Cefotaxime—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC15A2—multiple sclerosis	0.000205	0.0532	CbGpPWpGaD
Cefotaxime—Discomfort—Betamethasone—multiple sclerosis	0.000205	0.00235	CcSEcCtD
Cefotaxime—Discomfort—Dexamethasone—multiple sclerosis	0.000205	0.00235	CcSEcCtD
Cefotaxime—Haemoglobin—Methotrexate—multiple sclerosis	0.000205	0.00234	CcSEcCtD
Cefotaxime—Pain—Prednisolone—multiple sclerosis	0.000204	0.00233	CcSEcCtD
Cefotaxime—Hepatitis—Methotrexate—multiple sclerosis	0.000204	0.00233	CcSEcCtD
Cefotaxime—Haemorrhage—Methotrexate—multiple sclerosis	0.000204	0.00233	CcSEcCtD
Cefotaxime—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000199	0.00228	CcSEcCtD
Cefotaxime—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000199	0.00228	CcSEcCtD
Cefotaxime—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000199	0.00228	CcSEcCtD
Cefotaxime—Ill-defined disorder—Prednisone—multiple sclerosis	0.000197	0.00225	CcSEcCtD
Cefotaxime—Feeling abnormal—Prednisolone—multiple sclerosis	0.000196	0.00225	CcSEcCtD
Cefotaxime—Shock—Betamethasone—multiple sclerosis	0.000195	0.00224	CcSEcCtD
Cefotaxime—Shock—Dexamethasone—multiple sclerosis	0.000195	0.00224	CcSEcCtD
Cefotaxime—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000195	0.00223	CcSEcCtD
Cefotaxime—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000195	0.00223	CcSEcCtD
Cefotaxime—Angioedema—Prednisone—multiple sclerosis	0.000194	0.00222	CcSEcCtD
Cefotaxime—Erythema multiforme—Methotrexate—multiple sclerosis	0.000192	0.00221	CcSEcCtD
Cefotaxime—Malaise—Prednisone—multiple sclerosis	0.000191	0.00219	CcSEcCtD
Cefotaxime—Urticaria—Prednisolone—multiple sclerosis	0.000189	0.00217	CcSEcCtD
Cefotaxime—Pain—Triamcinolone—multiple sclerosis	0.000187	0.00215	CcSEcCtD
Cefotaxime—Vomiting—Mitoxantrone—multiple sclerosis	0.000185	0.00211	CcSEcCtD
Cefotaxime—Convulsion—Prednisone—multiple sclerosis	0.000184	0.0021	CcSEcCtD
Cefotaxime—Rash—Mitoxantrone—multiple sclerosis	0.000183	0.0021	CcSEcCtD
Cefotaxime—Dermatitis—Mitoxantrone—multiple sclerosis	0.000183	0.00209	CcSEcCtD
Cefotaxime—Headache—Mitoxantrone—multiple sclerosis	0.000182	0.00208	CcSEcCtD
Cefotaxime—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00018	0.00207	CcSEcCtD
Cefotaxime—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00018	0.00206	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000179	0.00205	CcSEcCtD
Cefotaxime—Discomfort—Prednisone—multiple sclerosis	0.000178	0.00204	CcSEcCtD
Cefotaxime—Hypersensitivity—Prednisolone—multiple sclerosis	0.000175	0.00201	CcSEcCtD
Cefotaxime—Urticaria—Triamcinolone—multiple sclerosis	0.000174	0.00199	CcSEcCtD
Cefotaxime—Urticaria—Methylprednisolone—multiple sclerosis	0.000174	0.00199	CcSEcCtD
Cefotaxime—Body temperature increased—Triamcinolone—multiple sclerosis	0.000173	0.00198	CcSEcCtD
Cefotaxime—Anaphylactic shock—Prednisone—multiple sclerosis	0.000173	0.00198	CcSEcCtD
Cefotaxime—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000173	0.00198	CcSEcCtD
Cefotaxime—Nausea—Mitoxantrone—multiple sclerosis	0.000172	0.00198	CcSEcCtD
Cefotaxime—Shock—Prednisone—multiple sclerosis	0.00017	0.00195	CcSEcCtD
Cefotaxime—Pain—Dexamethasone—multiple sclerosis	0.00017	0.00195	CcSEcCtD
Cefotaxime—Pain—Betamethasone—multiple sclerosis	0.00017	0.00195	CcSEcCtD
Cefotaxime—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000164	0.00188	CcSEcCtD
Cefotaxime—Feeling abnormal—Betamethasone—multiple sclerosis	0.000164	0.00188	CcSEcCtD
Cefotaxime—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000164	0.00188	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000162	0.00186	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000162	0.00186	CcSEcCtD
Cefotaxime—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000161	0.00185	CcSEcCtD
Cefotaxime—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000161	0.00184	CcSEcCtD
Cefotaxime—Malaise—Methotrexate—multiple sclerosis	0.00016	0.00183	CcSEcCtD
Cefotaxime—Leukopenia—Methotrexate—multiple sclerosis	0.000159	0.00182	CcSEcCtD
Cefotaxime—Urticaria—Betamethasone—multiple sclerosis	0.000158	0.00181	CcSEcCtD
Cefotaxime—Urticaria—Dexamethasone—multiple sclerosis	0.000158	0.00181	CcSEcCtD
Cefotaxime—Body temperature increased—Dexamethasone—multiple sclerosis	0.000157	0.0018	CcSEcCtD
Cefotaxime—Body temperature increased—Betamethasone—multiple sclerosis	0.000157	0.0018	CcSEcCtD
Cefotaxime—Abdominal pain—Betamethasone—multiple sclerosis	0.000157	0.0018	CcSEcCtD
Cefotaxime—Abdominal pain—Dexamethasone—multiple sclerosis	0.000157	0.0018	CcSEcCtD
Cefotaxime—Pruritus—Triamcinolone—multiple sclerosis	0.000155	0.00178	CcSEcCtD
Cefotaxime—Pruritus—Methylprednisolone—multiple sclerosis	0.000155	0.00177	CcSEcCtD
Cefotaxime—Convulsion—Methotrexate—multiple sclerosis	0.000153	0.00176	CcSEcCtD
Cefotaxime—Rash—Prednisolone—multiple sclerosis	0.00015	0.00172	CcSEcCtD
Cefotaxime—Dermatitis—Prednisolone—multiple sclerosis	0.00015	0.00172	CcSEcCtD
Cefotaxime—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000149	0.00171	CcSEcCtD
Cefotaxime—Headache—Prednisolone—multiple sclerosis	0.000149	0.00171	CcSEcCtD
Cefotaxime—Discomfort—Methotrexate—multiple sclerosis	0.000149	0.00171	CcSEcCtD
Cefotaxime—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000145	0.00166	CcSEcCtD
Cefotaxime—Feeling abnormal—Prednisone—multiple sclerosis	0.000143	0.00163	CcSEcCtD
Cefotaxime—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000142	0.00162	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000141	0.00162	CcSEcCtD
Cefotaxime—Nausea—Prednisolone—multiple sclerosis	0.000141	0.00162	CcSEcCtD
Cefotaxime—Pruritus—Betamethasone—multiple sclerosis	0.000141	0.00161	CcSEcCtD
Cefotaxime—Pruritus—Dexamethasone—multiple sclerosis	0.000141	0.00161	CcSEcCtD
Cefotaxime—Vomiting—Triamcinolone—multiple sclerosis	0.000139	0.0016	CcSEcCtD
Cefotaxime—Vomiting—Methylprednisolone—multiple sclerosis	0.000139	0.00159	CcSEcCtD
Cefotaxime—Rash—Triamcinolone—multiple sclerosis	0.000138	0.00158	CcSEcCtD
Cefotaxime—Dermatitis—Triamcinolone—multiple sclerosis	0.000138	0.00158	CcSEcCtD
Cefotaxime—Rash—Methylprednisolone—multiple sclerosis	0.000138	0.00158	CcSEcCtD
Cefotaxime—Dermatitis—Methylprednisolone—multiple sclerosis	0.000138	0.00158	CcSEcCtD
Cefotaxime—Urticaria—Prednisone—multiple sclerosis	0.000137	0.00158	CcSEcCtD
Cefotaxime—Headache—Triamcinolone—multiple sclerosis	0.000137	0.00157	CcSEcCtD
Cefotaxime—Headache—Methylprednisolone—multiple sclerosis	0.000137	0.00157	CcSEcCtD
Cefotaxime—Body temperature increased—Prednisone—multiple sclerosis	0.000137	0.00157	CcSEcCtD
Cefotaxime—Abdominal pain—Prednisone—multiple sclerosis	0.000137	0.00157	CcSEcCtD
Cefotaxime—Diarrhoea—Betamethasone—multiple sclerosis	0.000136	0.00156	CcSEcCtD
Cefotaxime—Diarrhoea—Dexamethasone—multiple sclerosis	0.000136	0.00156	CcSEcCtD
Cefotaxime—Nausea—Triamcinolone—multiple sclerosis	0.00013	0.00149	CcSEcCtD
Cefotaxime—Nausea—Methylprednisolone—multiple sclerosis	0.00013	0.00149	CcSEcCtD
Cefotaxime—Hypersensitivity—Prednisone—multiple sclerosis	0.000127	0.00146	CcSEcCtD
Cefotaxime—Vomiting—Dexamethasone—multiple sclerosis	0.000126	0.00145	CcSEcCtD
Cefotaxime—Vomiting—Betamethasone—multiple sclerosis	0.000126	0.00145	CcSEcCtD
Cefotaxime—Rash—Betamethasone—multiple sclerosis	0.000125	0.00144	CcSEcCtD
Cefotaxime—Rash—Dexamethasone—multiple sclerosis	0.000125	0.00144	CcSEcCtD
Cefotaxime—Dermatitis—Dexamethasone—multiple sclerosis	0.000125	0.00143	CcSEcCtD
Cefotaxime—Dermatitis—Betamethasone—multiple sclerosis	0.000125	0.00143	CcSEcCtD
Cefotaxime—Headache—Dexamethasone—multiple sclerosis	0.000124	0.00143	CcSEcCtD
Cefotaxime—Headache—Betamethasone—multiple sclerosis	0.000124	0.00143	CcSEcCtD
Cefotaxime—Pain—Methotrexate—multiple sclerosis	0.000124	0.00142	CcSEcCtD
Cefotaxime—Pruritus—Prednisone—multiple sclerosis	0.000122	0.0014	CcSEcCtD
Cefotaxime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—multiple sclerosis	0.000121	0.0313	CbGpPWpGaD
Cefotaxime—Feeling abnormal—Methotrexate—multiple sclerosis	0.000119	0.00137	CcSEcCtD
Cefotaxime—Diarrhoea—Prednisone—multiple sclerosis	0.000118	0.00136	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000118	0.00135	CcSEcCtD
Cefotaxime—Nausea—Dexamethasone—multiple sclerosis	0.000118	0.00135	CcSEcCtD
Cefotaxime—Nausea—Betamethasone—multiple sclerosis	0.000118	0.00135	CcSEcCtD
Cefotaxime—Urticaria—Methotrexate—multiple sclerosis	0.000115	0.00132	CcSEcCtD
Cefotaxime—Body temperature increased—Methotrexate—multiple sclerosis	0.000114	0.00131	CcSEcCtD
Cefotaxime—Abdominal pain—Methotrexate—multiple sclerosis	0.000114	0.00131	CcSEcCtD
Cefotaxime—Vomiting—Prednisone—multiple sclerosis	0.00011	0.00126	CcSEcCtD
Cefotaxime—Rash—Prednisone—multiple sclerosis	0.000109	0.00125	CcSEcCtD
Cefotaxime—Dermatitis—Prednisone—multiple sclerosis	0.000109	0.00125	CcSEcCtD
Cefotaxime—Headache—Prednisone—multiple sclerosis	0.000108	0.00124	CcSEcCtD
Cefotaxime—Hypersensitivity—Methotrexate—multiple sclerosis	0.000107	0.00122	CcSEcCtD
Cefotaxime—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.000105	0.0272	CbGpPWpGaD
Cefotaxime—Nausea—Prednisone—multiple sclerosis	0.000103	0.00118	CcSEcCtD
Cefotaxime—Pruritus—Methotrexate—multiple sclerosis	0.000102	0.00117	CcSEcCtD
Cefotaxime—Diarrhoea—Methotrexate—multiple sclerosis	9.89e-05	0.00113	CcSEcCtD
Cefotaxime—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	9.53e-05	0.0247	CbGpPWpGaD
Cefotaxime—Vomiting—Methotrexate—multiple sclerosis	9.19e-05	0.00105	CcSEcCtD
Cefotaxime—Rash—Methotrexate—multiple sclerosis	9.12e-05	0.00104	CcSEcCtD
Cefotaxime—Dermatitis—Methotrexate—multiple sclerosis	9.11e-05	0.00104	CcSEcCtD
Cefotaxime—Cefazolin—ALB—multiple sclerosis	9.07e-05	0.0121	CrCbGaD
Cefotaxime—Headache—Methotrexate—multiple sclerosis	9.06e-05	0.00104	CcSEcCtD
Cefotaxime—Ceftriaxone—ALB—multiple sclerosis	8.6e-05	0.0114	CrCbGaD
Cefotaxime—Nausea—Methotrexate—multiple sclerosis	8.59e-05	0.000984	CcSEcCtD
Cefotaxime—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	8.01e-05	0.0208	CbGpPWpGaD
Cefotaxime—Cefalotin—ALB—multiple sclerosis	7.53e-05	0.01	CrCbGaD
Cefotaxime—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	7.34e-05	0.019	CbGpPWpGaD
Cefotaxime—Cephalexin—ALB—multiple sclerosis	6.84e-05	0.00911	CrCbGaD
Cefotaxime—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	6.69e-05	0.0173	CbGpPWpGaD
Cefotaxime—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	6.66e-05	0.0173	CbGpPWpGaD
Cefotaxime—SLC22A11—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	6.3e-05	0.0163	CbGpPWpGaD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	5.72e-05	0.0148	CbGpPWpGaD
Cefotaxime—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	5.6e-05	0.0145	CbGpPWpGaD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	5.4e-05	0.014	CbGpPWpGaD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	4.8e-05	0.0125	CbGpPWpGaD
Cefotaxime—SLC22A11—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	4.77e-05	0.0124	CbGpPWpGaD
Cefotaxime—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	4.67e-05	0.0121	CbGpPWpGaD
Cefotaxime—SLC15A2—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	4.41e-05	0.0114	CbGpPWpGaD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	4.33e-05	0.0112	CbGpPWpGaD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	4.09e-05	0.0106	CbGpPWpGaD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	4.01e-05	0.0104	CbGpPWpGaD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	3.64e-05	0.00944	CbGpPWpGaD
Cefotaxime—SLC22A11—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	3.34e-05	0.00865	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	3.2e-05	0.0083	CbGpPWpGaD
Cefotaxime—SLC15A2—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	3.08e-05	0.00799	CbGpPWpGaD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	3.04e-05	0.00788	CbGpPWpGaD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	3.03e-05	0.00785	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	2.9e-05	0.00753	CbGpPWpGaD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	2.86e-05	0.00742	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	2.74e-05	0.00712	CbGpPWpGaD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	2.54e-05	0.0066	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	2.44e-05	0.00633	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.43e-05	0.00629	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.24e-05	0.00581	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.2e-05	0.00571	CbGpPWpGaD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	2.12e-05	0.00551	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.08e-05	0.00539	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	2.04e-05	0.00528	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.92e-05	0.00497	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.85e-05	0.0048	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.77e-05	0.00459	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.74e-05	0.00451	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.7e-05	0.00439	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.64e-05	0.00426	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.57e-05	0.00406	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.54e-05	0.004	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.54e-05	0.00399	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.46e-05	0.00379	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.45e-05	0.00377	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.29e-05	0.00335	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.22e-05	0.00316	CbGpPWpGaD
Cefotaxime—SLC22A11—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.2e-05	0.00311	CbGpPWpGaD
Cefotaxime—SLC15A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.11e-05	0.00288	CbGpPWpGaD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.09e-05	0.00283	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.08e-05	0.0028	CbGpPWpGaD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.03e-05	0.00267	CbGpPWpGaD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—ALB—multiple sclerosis	9.16e-06	0.00237	CbGpPWpGaD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—ALB—multiple sclerosis	7.65e-06	0.00198	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.1e-06	0.00158	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.64e-06	0.00146	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.54e-06	0.00144	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.23e-06	0.00136	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—ALB—multiple sclerosis	4.65e-06	0.00121	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.88e-06	0.00101	CbGpPWpGaD
